Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.

Recruiting Observational Study
Neurologically Unimpaired Elderly Participants Subjective Cognitive Decline (SCD) Mild Cognitive Impairment (MCI) Major Neurocognitive Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
60 and older
Sex
Any
Study type
Observational
Participants needed
390 (estimated)
Sponsor
Casa di Cura IGEA · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The first aim of the observational study is the translation, cross-cultural adaptation and validation of functional and behavioral scales used in the diagnosis of neurodegenerative diseases, for which a formal version in Italian is not available at present. In particular, the study includes the following functional and behavioral scales: the Katz's index (Basic Activities of Daily Living, BADL), t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 60 years; * Availability of an informant/caregiver, able to judge their functional abilities. For neurologically unimpaired elderly: \- Normal performance on the Mini Mental State Examination (Folstein et al. 1975; Foderaro et al., 2022). For clinical groups: Conditio…
Contacts

Sabrina Guzzetti, Psychologist

+390248593315

s.guzzetti@casadicurigea.it

CONTACT

Laura Veronelli, PhD

+390264483704

laura.veronelli@unimib.it

CONTACT